Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	28^th April 2023

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,698,847 (2.054%)		-
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	285,200 (0.125%)		1,304,800 (0.570%)
Total	4,984,047 (2.179%)		1,304,800 (0.570%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Sale	43	111.98
Purchase	350	111.53
Sale	149	111.15
Purchase	12	111.52
Sale	51	111.75
Purchase	100	111.59
Purchase	10	111.58
Purchase	2,628	111.49
Purchase	1,295	111.45
Purchase	600	111.43
Purchase	600	111.46
Purchase	241	111.48
Purchase	11	111.57
Purchase	1,200	111.47
Purchase	10	111.65
Sale	76	111.65
Purchase	9,224	111.50
Purchase	300	111.42
Purchase	10	111.68
Purchase	171	111.51
Purchase	149	111.16
Purchase	100	111.55
Purchase	200	111.56
Purchase	200	111.82
Purchase	300	111.70
Sale	53	111.76
Purchase	100	112.12
Purchase	193	111.78
Purchase	60	112.10
Purchase	100	111.69
Purchase	214	111.53
Purchase	100	111.15
Purchase	100	112.03
Purchase	5	111.61
Purchase	200	111.52
Purchase	1	111.22
Purchase	155	111.28
Purchase	1	111.59
Purchase	5	111.58
Purchase	73	111.27
Purchase	119	111.49
Purchase	300	111.66
Purchase	22	111.24
Purchase	105	111.39
Purchase	100	111.44
Purchase	13	111.43
Purchase	11	111.46
Purchase	12	111.26
Purchase	309	111.60
Purchase	38	111.47
Purchase	30	111.37
Purchase	5	111.23
Purchase	5	111.40
Purchase	238	111.99
Purchase	10	111.72
Purchase	300	111.95
Purchase	100	111.97
Purchase	100	111.35
Sale	897	111.16
Purchase	15	111.41
Purchase	20	111.33
Purchase	22	111.32
Purchase	100	111.55
Purchase	500	111.71
Purchase	100	111.74
Purchase	400	111.64
Purchase	200	111.89
Purchase	200	111.63
Purchase	100	111.91
Purchase	51	111.76
Purchase	2,527	111.16
Purchase	100	112.10
Purchase	842	111.87
Purchase	1,272	111.69
Purchase	1,074	111.53
Purchase	236	112.01
Purchase	15	111.90
Purchase	1,342	111.15
Purchase	4,206	111.29
Purchase	481	111.61
Purchase	6,855	111.75
Purchase	829	111.22
Purchase	1,627	111.84
Purchase	3,361	111.28
Purchase	13,865	111.30
Purchase	969	111.59
Purchase	5,295	111.58
Purchase	3,789	111.27
Purchase	822	111.62
Purchase	18,109	111.49
Purchase	1,352	111.38
Purchase	16,973	112.00
Sale	31,745	112.00
Purchase	912	111.66
Purchase	3,445	111.25
Purchase	927	111.24
Purchase	8,794	111.39
Purchase	4,287	111.44
Purchase	5,719	111.45
Purchase	1,218	111.43
Purchase	3,404	111.46
Purchase	170	111.48
Purchase	1,233	111.57
Purchase	1,222	111.26
Purchase	8,270	111.60
Sale	1,016	111.60
Purchase	3,700	111.47
Sale	38	111.47
Purchase	2,387	111.37
Purchase	1,140	111.65
Purchase	555	111.23
Purchase	6,429	111.40
Purchase	3,158	111.99
Purchase	13,513	111.50
Purchase	318	111.42
Purchase	737	111.68
Purchase	20	111.72
Purchase	2,115	111.95
Purchase	5,000	111.51
Purchase	2,260	111.92
Purchase	123	111.97
Purchase	901	111.96
Purchase	503	111.31
Purchase	1,133	111.35
Purchase	403	111.18
Purchase	2,320	111.16
Purchase	652	111.41
Purchase	3,935	111.33
Purchase	7	111.32
Purchase	525	111.55
Purchase	3	111.71
Purchase	3,959	111.79
Purchase	291	111.93
Purchase	839	111.54
Purchase	114	111.67
Purchase	320	111.74
Purchase	160	111.73
Purchase	104	111.56
Purchase	113	111.64
Purchase	3,358	111.80
Purchase	1	111.17
Purchase	761	111.36
Purchase	204	111.91
Purchase	160	111.85
Purchase	5	111.21
Purchase	5	111.19
Purchase	258	111.94
Purchase	185	111.20
Purchase	558	111.34
Purchase	1,062	111.76
Purchase	1	111.13
Purchase	120	111.86
Purchase	1	112.04

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price (USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	1^st May 2023
Contact name	Sirina Kumar
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND
RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING
OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND
RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	1,100	90.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	11,500	110.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Written	262,400	115.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	42,500	120.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	55,400	110.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	2,900	80.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	201,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	221,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	254,200	100.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	100,000	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	46,600	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	155,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	200,000	100.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Purchased	4,200	112.00	American	5/5/2023
IE00BQPVQZ61	Call Option	Purchased	4,200	113.00	American	5/5/2023
IE00BQPVQZ61	Put Option	Purchased	3,400	112.00	American	5/5/2023
IE00BQPVQZ61	Put Option	Purchased	3,400	113.00	American	5/5/2023
IE00BQPVQZ61	Put Option	Purchased	3,500	95.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	300	110.00	American	7/21/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1088801

Time of Receipt (offset from UTC): 20230501T120322+0100